The competition for generics' 180-day marketing exclusivity is fierce, and Dr. Reddy's Laboratories filed the first court case calling into question FDA's methods for determining exclusivity on a patent-by-patent basis.
Thomas J. Parker
Advertisement
Thomas J. Parker, Esq., is a counselor for Intellectual Property Practice Group in the New York office of Coudert Brothers LLP.
Articles by Thomas J. Parker
Advertisement
Latest Updated Articles
Generics Battle Heats UpPublished: April 1st 2003 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Novartis Enters $12 Billion Definitive Merger Agreement to Acquire Avidity Biosciences
3
ACS Calls Obesity a Condition That Must Be Treated with Medication and Surgery
4
Study Claims Ozempic Lowers Biological Age
5
